SIDE-BY-SIDE EVIDENCE
Compare evidence.
Keep the context.
Select 2–3 profiles from the English Library. Class and grade describe evidence and regulatory context, not comparative effectiveness or suitability for an individual.
Choose profilesSIDE-BY-SIDE EVIDENCE VIEW
Compare selected profiles
| Molecule |  Oxymetholone | Erythropoietin / EPO | Oxandrolone |
|---|---|---|---|
| Research Topic | Clinical / Endocrine Pharmacology | Clinical / Endocrine Pharmacology | Clinical / Endocrine Pharmacology |
| Pharmacology | Oral anabolic-androgenic steroid medicine in narrow contexts | Erythropoiesis-stimulating hormone / medicine family | Oral anabolic-androgenic steroid with product-specific medical history |
| PrimeCore Class | Class BInvestigational | Class AApproved in a bounded context | Class BInvestigational |
| Evidence Grade | Grade DLimited / observational evidence | Grade AStrong regulatory + clinical evidence | Grade DLimited / observational evidence |
| Evidence boundary | Oxymetholone is classified here as Oral anabolic-androgenic steroid medicine in narrow contexts. Prescription evidence is tied to selected anaemia contexts and monitored products. U.S. prescription labeling has existed for defined anaemia indications; it is controlled and prohibited by WADA at all times. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions. | EPO is an erythropoietic hormone and an ambiguous catalogue label, not a verified product identity. Authorised epoetin medicines treat selected anaemias, with risks including hypertension and thrombosis. Specific ESA warnings include stroke, cardiovascular events and tumour progression in defined settings. No endurance-enhancement recommendation is made. | Oxandrolone is classified here as Oral anabolic-androgenic steroid with product-specific medical history. Bounded medical evidence does not establish safety or effectiveness for physique or athletic use. A controlled anabolic steroid in the United States; exact current approved-product status must be checked and WADA prohibits it at all times. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions. |
| Unknowns | Insufficient data in the current dataset | Insufficient data in the current dataset | Insufficient data in the current dataset |
| Limitations |
| English translation is not yet verified for 1 excerpt(s). This is a language gap, not an absence of risks or uncertainty. Read original excerpts (Thai / mixed language)
|
|
| Sources | |||
| Read more | Read English overview | Read English overview | Read English overview |
This table does not compare doses, cross-trial outcomes or individual suitability. Missing information does not establish an absence of risk.
Choose another comparisonContinue reading
Missing fields mean information is unavailable in the current structured dataset, not that a molecule has no risks or uncertainties. English translations retain the original evidence boundaries. Where translation is not yet verified, the original Thai excerpts remain available under an explicit label. Sources retain their original language.
10 questions before drawing conclusions